Court Orders Gilead to Pay Merck $2.54 Billion in Patent Case -Reuters
December 15 2016 - 6:05PM
Dow Jones News
A Delaware jury ordered Gilead Sciences Inc. (GILD) to pay Merck
& Co. (MRK) $2.54 billion of royalties in a patent lawsuit,
Reuters reported Thursday.
The jury found a Merck patent on hepatitis C drugs was valid,
the report said.
Full story at
http://www.reuters.com/article/us-gilead-sciences-merck-co-verdict-idUSKBN1442U9
Write to nymonitoring@dowjones.com
(END) Dow Jones Newswires
December 15, 2016 17:46 ET (22:46 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Sep 2023 to Sep 2024